Scientists find natural mimetics of anti-cancer and anti-aging drugs

ea1e96d9-f897-440f-bd93-5244b29f1610articleimage.jpg

04 Dec 2017 --- Researchers from the Biogerontology Research Foundation in the UK, Insilico Medicine, Life Extension and other institutions have announced the publication of a landmark study in the journal Aging on the identification of natural mimetics of metformin and rapamycin.

Metformin, a common Type 2 diabetes drug, and rapamycin, a common anti-rejection drug, have both been shown to have substantial anti-aging and anti-cancer effects in a variety of model organisms. However, both compounds have known side effects and are regulated drugs for existing disease indications, factors that problematize their off-label use as healthspan-extending drugs.

Natural compounds mimic crucial drugs
In the Aging study, the researchers applied deep-learned neural networks to profile the safety and gene- and pathway-level similarity of more than 800 natural compounds to metformin and rapamycin, in an effort to identify natural compounds that can mimic the effects of these anti-cancer and anti-aging drugs while remaining free of the adverse effects associated with them.

“Earlier this year we launched Young.AI, a comprehensive system utilizing the recent advances in deep learning for tracking a variety of aging biomarkers,” says Alex Zhavoronkov, Ph.D., co-author of the study, founder of Insilico Medicine and Chief Science Officer of the Biogerontology Research Foundation. “I hope that the consumers using the Longevity AI will start using it. One of the goals of our group is to identify the combinations of molecules that achieve the desired effects.”

The researchers’ analysis identified many novel candidate metformin and rapamycin mimetics that have been previously unreported as such. In particular, they identified allantoin and ginsenoside as strong mimetics of metformin, epigallocatechin gallate and isoliquiritigenin as strong mimetics of rapamycin, and withaferin A as a strong mimetic of both. Additionally, their analysis also identified four previously unexplored natural compounds as fairly strong mimetics of rapamycin.

“Aging is not recognized as a disease, so we need strong potential geroprotectors of natural origin on the market. Supplements that slow down aging, affecting the key mechanisms of aging at the molecular and cellular level,” says Alexey Moskalev, Ph.D., a co-author of the study.

These findings are significant because, as naturally occurring compounds, such nutraceuticals are not subject to regulation by the FDA and other regulatory bodies. Furthermore, because the researchers induced a deep-learning based classification of the safety profiles associated with these compounds, the novel candidate mimetics the study identified are likely to have less adverse effects than metformin and rapamycin, though this needs to be further validated by clinical testing.

“This study is significant not only for the identification of novel candidate mimetics of metformin and rapamycin – which as natural compounds are not subject to regulatory bodies like the FDA and which have higher-scoring safety profiles as indicated by our deep-learned safety profile classification analysis – but also for demonstrating particularly powerful screening methods that can be applied to the identification of novel and safe mimetics of other known anti-cancer and healthspan-extending drugs and compounds,” says Franco Cortese, co-author of the study and Deputy Director of the Biogerontology Research Foundation.

The paper can be accessed here.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Regulatory News

Oleic acid CHD claims success: US FDA approves qualified claim petition on high level foods 

20 Nov 2018 --- The US Food and Drug Administration (FDA) has responded positively to a petition for a new qualified health claim for edible oils containing oleic acid. As a result, products with an oleic acid content upward of 70 percent, such as certain olive, canola and sunflower oils, can be labeled as carrying cardiovascular benefits, but only when replacing heart-damaging saturated fat.

Health & Nutrition News

Gluten-free diet health benefits actually down to change in dietary fiber sources, study finds

19 Nov 2018 --- Following a gluten-free diet can lead to a reduction of intestinal discomfort, such as bloating, but this may be due to a change in dietary fiber composition, suggest Danish researchers. The University of Copenhagen study notes that the healthy, gluten-free diets in their study required a shift of fiber sources from wheat and rye to vegetables, brown rice, corn, oat and quinoa, and that certain health improvements were down to these sources – not the absence of gluten. 

Health & Nutrition News

Metabolic surgery: Transformational or quick-fix?

19 Nov 2018 --- More than one-third of US adults are obese and some of the lead causes of non-communicable disease’ deaths – such as stroke, diabetes and cancers – are obesity-related. Although a healthy diet and lifestyle are key to healthy weight management, more drastic measures, such as bariatric surgery, are becoming more commonplace as obesity levels rise. NutritionInsight takes a look into the discussion around bariatric surgery, following research presented during last week’s Obesity Week event based in Tennessee, US.

Health & Nutrition News

Health Logics launches mood and cognition-enhancing supplement

16 Nov 2018 --- Health Logics is launching a dietary supplement containing S-adenosylmethionine. Also known as SAM-e, produced by advanced biotech company Gnosis, the ingredient is touted as improving joint, brain and liver function, and enhances mood and cognition.

Health & Nutrition News

Navigating the digestive health space: Probiotic strain specificity and microbiome key to future NPD

16 Nov 2018 --- Emerging science linking a healthy microbiome to nearly every facet of health, as well as the ongoing media reporting on probiotics, have helped drive consumer interest in gut health. This growing area offers a wealth of opportunities to formulators, but due to regulatory demands and increasing consumer scrutiny, a clear view of how to navigate this space is vital.

More Articles
URL : http://www.nutritioninsight.com:80/news/scientists-find-natural-mimetics-of-anti-cancer-and-anti-aging-drugs.html